Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or

Chimerix Inc (CMRX)

Chimerix Inc (CMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Chimerix: Q2 Earnings Snapshot

Chimerix: Q2 Earnings Snapshot

CMRX : 0.8898 (+1.69%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

EQNX::TICKER_START (NYSE:NNVC),(NASDAQ:BCRX),(NASDAQ:VERU),(NASDAQ:CMRX),(NASDAQ:SIGA) EQNX::TICKER_END

BCRX : 8.11 (-0.49%)
NNVC : 1.5700 (-0.63%)
VERU : 0.7798 (-2.67%)
CMRX : 0.8898 (+1.69%)
SIGA : 8.43 (-1.17%)
Rapid Advancements of Innovative Antiviral – COVID-19 Drugs Generating Major Growth in Global Antiviral Drugs Market

NNVC : 1.5700 (-0.63%)
VERU : 0.7798 (-2.67%)
CMRX : 0.8898 (+1.69%)
SIGA : 8.43 (-1.17%)
Chimerix: Q1 Earnings Snapshot

Chimerix: Q1 Earnings Snapshot

CMRX : 0.8898 (+1.69%)
Chimerix: Q4 Earnings Snapshot

Chimerix: Q4 Earnings Snapshot

CMRX : 0.8898 (+1.69%)
Chimerix: Q3 Earnings Snapshot

Chimerix: Q3 Earnings Snapshot

CMRX : 0.8898 (+1.69%)
Chimerix: Q2 Earnings Snapshot

Chimerix: Q2 Earnings Snapshot

CMRX : 0.8898 (+1.69%)
Chimerix: Q1 Earnings Snapshot

Chimerix: Q1 Earnings Snapshot

CMRX : 0.8898 (+1.69%)
Chimerix: Q4 Earnings Snapshot

Chimerix: Q4 Earnings Snapshot

CMRX : 0.8898 (+1.69%)
Rubric Capital Management Sends Letter to Chimerix Board of Directors

Rubric Capital Management LP (“Rubric”), an investment adviser whose managed funds and accounts collectively own approximately 8.5% of the common stock of Chimerix, Inc. (“Chimerix” or the “Company”)...

CMRX : 0.8898 (+1.69%)

Barchart Exclusives

3 Dividend Kings With Unstoppable Dividend Growth Potential
Discover three quality companies with healthy financials, low dividend payout ratios, and a history of incredible dividend growth. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.

Free Barchart Webinar